In this webinar, our expert speaker will explore the therapeutic potential of miRNA- targeting treatments, outlining cutting-edge research that is identifying new miRNA targets.

Genomics is a powerful tool for conserving endangered species, informing researchers of taxonomy and population connectivity and helping to develop strategies for mitigating disease and the effects of climate change.

Comprehensive genome analyses that provide information on single-nucleotide polymorphisms, structural variants, copy number variations and epigenetic markers are changing the landscape of genomics.

CRISPR-Cas9 gene editing is an essential functional genomics tool, facilitating the cataloging of genomic variations linked to human diseases for the discovery and validation of novel drug targets.

Pharmacogenomic testing uses a patient’s genome to identify their response to a drug, forming a key part of personalized medicine.
Hundreds of clinical pharmacogenomics (PGx) tests are currently available on the market in the United States. With so many tests available, how can you determine that a test is clinically and analytically valid and holds clinical utility?
In this webinar, our expert speaker will outline the ACCE Model Project Framework as a tool for evaluating pharmacogenomic tests, describing the key considerations to take into account when implementing these tests.
You’ll learn how to select the genetic variants to be tested, choose the appropriate genotyping technology and develop laboratory procedures for sample processing and data analysis.

In this webinar, you’ll hear from two experts about their research into microbial communities and the impact of nanopore sequencing technologies on their work.